Published in Neurobiol Aging on March 11, 1999
Neuroanatomical substrates of age-related cognitive decline. Psychol Bull (2011) 2.75
Age-related changes in midbrain dopaminergic regulation of the human reward system. Proc Natl Acad Sci U S A (2008) 1.49
Cerebral aging: integration of brain and behavioral models of cognitive function. Dialogues Clin Neurosci (2001) 1.34
A review of functional brain imaging correlates of successful cognitive aging. Biol Psychiatry (2011) 1.26
Separating function from structure in perfusion imaging of the aging brain. Hum Brain Mapp (2009) 1.24
Transcriptome analysis of synaptoneurosomes identifies neuroplasticity genes overexpressed in incipient Alzheimer's disease. PLoS One (2009) 1.19
I. Longitudinal changes in aging brain function. Neurobiol Aging (2006) 1.12
FMRI of working memory in patients with mild cognitive impairment and probable Alzheimer's disease. Eur Radiol (2005) 1.09
Fluoxetine increases relative metabolic rate in prefrontal cortex in impulsive aggression. Psychopharmacology (Berl) (2004) 1.07
Memory training interventions for older adults: a meta-analysis. Aging Ment Health (2012) 1.05
Obstructive sleep apnea and age: a double insult to brain function? Am J Respir Crit Care Med (2010) 1.03
Memory training and strategy use in older adults: results from the ACTIVE study. Psychol Aging (2011) 1.01
Neural basis for recognition confidence in younger and older adults. Psychol Aging (2009) 0.89
Effects of sex and normal aging on regional brain activation during verbal memory performance. Neurobiol Aging (2008) 0.84
Anterior and posterior cingulate cortex volume in healthy adults: effects of aging and gender differences. Brain Res (2011) 0.82
Bigger is better! Hippocampal volume and declarative memory performance in healthy young men. Brain Struct Funct (2012) 0.79
Schizophrenia patients lack normal positive correlation between age and brain response during verbal learning. Am J Geriatr Psychiatry (2009) 0.77
The relationship between cerebral glucose metabolism and age: report of a large brain PET data set. PLoS One (2012) 0.76
Differences between patterns of brain activity associated with semantics and those linked with phonological processing diminish with age. PLoS One (2014) 0.76
The implications of age-related neurofunctional compensatory mechanisms in executive function and language processing including the new Temporal Hypothesis for Compensation. Front Hum Neurosci (2015) 0.76
Indestructible plastic: the neuroscience of the new aging brain. Front Hum Neurosci (2014) 0.75
FDG-PET scans in patients with Kraepelinian and non-Kraepelinian schizophrenia. Eur Arch Psychiatry Clin Neurosci (2015) 0.75
Current concepts in mild cognitive impairment. Arch Neurol (2001) 18.09
The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease. Neurology (1989) 16.83
A new rating scale for Alzheimer's disease. Am J Psychiatry (1984) 15.16
The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part V. A normative study of the neuropsychological battery. Neurology (1994) 5.81
Donepezil improves cognition and global function in Alzheimer disease: a 15-week, double-blind, placebo-controlled study. Donepezil Study Group. Arch Intern Med (1998) 4.43
Practice parameter: management of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology (2001) 3.74
Cholinergic markers in elderly patients with early signs of Alzheimer disease. JAMA (1999) 3.22
Regional distribution of neuritic plaques in the nondemented elderly and subjects with very mild Alzheimer disease. Arch Neurol (1998) 3.20
Consortium to establish a registry for Alzheimer's disease (CERAD) clinical and neuropsychological assessment of Alzheimer's disease. Psychopharmacol Bull (1988) 2.50
Diffusion measurements in intracranial hematomas: implications for MR imaging of acute stroke. AJNR Am J Neuroradiol (2000) 2.41
A longitudinal study of Alzheimer's disease: measurement, rate, and predictors of cognitive deterioration. Am J Psychiatry (1994) 2.41
Prediction of antidepressant effects of sleep deprivation by metabolic rates in the ventral anterior cingulate and medial prefrontal cortex. Am J Psychiatry (1999) 2.32
Detection and staging of dementia in Alzheimer's disease. Use of the neuropsychological measures developed for the Consortium to Establish a Registry for Alzheimer's Disease. Arch Neurol (1992) 2.19
Empirical assessment of the factorial structure of clinical symptoms in schizophrenia. A multisite, multimodel evaluation of the factorial structure of the Positive and Negative Syndrome Scale. The PANSS Study Group. Psychopathology (1997) 2.19
New insights into the link between cardiovascular disease and depression. Int J Clin Pract (2007) 2.18
Neurofibrillary tangles in nondemented elderly subjects and mild Alzheimer disease. Arch Neurol (1999) 2.02
Behavioral and cognitive effects of caffeine in boys and adult males. J Nerv Ment Dis (1981) 1.90
Regional glucose metabolic changes after learning a complex visuospatial/motor task: a positron emission tomographic study. Brain Res (1992) 1.90
Selective reductions in prefrontal glucose metabolism in murderers. Biol Psychiatry (1994) 1.88
Patterns of risk in first-degree relatives of patients with Alzheimer's disease. Arch Gen Psychiatry (1994) 1.84
The Alzheimer's disease assessment scale: an instrument for assessing treatment efficacy. Psychopharmacol Bull (1983) 1.81
Limbic circuitry in patients with autism spectrum disorders studied with positron emission tomography and magnetic resonance imaging. Am J Psychiatry (2000) 1.81
Reliability of the family history method in genetic studies of Alzheimer's disease and related dementias. Am J Psychiatry (1986) 1.80
Serotonergic studies in patients with affective and personality disorders. Correlates with suicidal and impulsive aggressive behavior. Arch Gen Psychiatry (1989) 1.79
Genome scan of schizophrenia. Am J Psychiatry (1998) 1.74
Ventricular enlargement in poor-outcome schizophrenia. Biol Psychiatry (1998) 1.70
Neuropeptide abnormalities in patients with early Alzheimer disease. Arch Gen Psychiatry (1999) 1.62
Guanfacine treatment of cognitive impairment in schizophrenia. Neuropsychopharmacology (2001) 1.61
Survival after resection of gastric cancer and prognostic relevance of systematic lymph node dissection: twenty years experience in Taiwan. World J Surg (1995) 1.61
Symptoms, cognitive functioning, and adaptive skills in geriatric patients with lifelong schizophrenia: a comparison across treatment sites. Am J Psychiatry (1998) 1.60
Olfactory memory in unmedicated schizophrenics. Schizophr Res (1993) 1.59
Effects of rivastigmine on cognitive function in patients with traumatic brain injury. Neurology (2006) 1.55
Eye tracking, attention, and schizotypal symptoms in nonpsychotic relatives of patients with schizophrenia. Arch Gen Psychiatry (1997) 1.51
Positron emission tomographic measurements of pulvinar activity during an attention task. J Neurosci (1990) 1.50
A long-term, multicenter, open-label study of risperidone in elderly patients with psychosis. On behalf of the Risperidone Working Group. Int J Geriatr Psychiatry (2000) 1.47
The longitudinal stability of cognitive impairment in schizophrenia. Mini-mental state scores at one- and two-year follow-ups in geriatric in-patients. Br J Psychiatry (1995) 1.46
Deterioration on the Blessed test in Alzheimer's disease: longitudinal data and their implications for clinical trials and identification of subtypes. Psychiatry Res (1992) 1.45
Learning and memory in combat veterans with posttraumatic stress disorder. Am J Psychiatry (1995) 1.44
Cognitive deficits in schizophrenia. Psychiatr Clin North Am (1993) 1.44
Six-year follow-up study of cognitive and functional status across the lifespan in schizophrenia: a comparison with Alzheimer's disease and normal aging. Am J Psychiatry (2001) 1.43
Three-dimensional analysis with MRI and PET of the size, shape, and function of the thalamus in the schizophrenia spectrum. Am J Psychiatry (1999) 1.43
Anterior cingulate gyrus volume and glucose metabolism in autistic disorder. Am J Psychiatry (1997) 1.42
Shape and size of the corpus callosum in schizophrenia and schizotypal personality disorder. Schizophr Res (2000) 1.41
Dextroamphetamine. Its cognitive and behavioral effects in normal and hyperactive boys and normal men. Arch Gen Psychiatry (1980) 1.41
Serum alpha-fetoprotein in the early stage of human hepatocellular carcinoma. Gastroenterology (1984) 1.41
Reduced prefrontal and increased subcortical brain functioning assessed using positron emission tomography in predatory and affective murderers. Behav Sci Law (1998) 1.37
Cognitive decline in late-life schizophrenia: a longitudinal study of geriatric chronically hospitalized patients. Biol Psychiatry (1999) 1.36
Mitochondrial damage in Alzheimer's disease varies with apolipoprotein E genotype. Ann Neurol (2000) 1.35
Development of neuropharmacologically based behavioral assessments of impulsive aggressive behavior. J Neuropsychiatry Clin Neurosci (1991) 1.33
Familial aggregation in Alzheimer's disease: comparison of risk among relatives of early-and late-onset cases, and among male and female relatives in successive generations. Neurology (1988) 1.32
Regional and global changes in cerebral diffusion with normal aging. AJNR Am J Neuroradiol (2001) 1.32
Cerebral glucography with positron tomography. Use in normal subjects and in patients with schizophrenia. Arch Gen Psychiatry (1982) 1.30
Severity of symptoms in chronically institutionalized geriatric schizophrenic patients. Am J Psychiatry (1995) 1.30
d,l-fenfluramine response in impulsive personality disorder assessed with [18F]fluorodeoxyglucose positron emission tomography. Neuropsychopharmacology (1999) 1.28
Feeling unreal: a PET study of depersonalization disorder. Am J Psychiatry (2000) 1.26
Cerebral infarcts in patients with autopsy-proven Alzheimer's disease: CERAD, part XVIII. Consortium to Establish a Registry for Alzheimer's Disease. Neurology (1998) 1.26
Postmortem studies in schizophrenia. Schizophr Bull (1998) 1.23
Cortisol and Alzheimer's disease, I: Basal studies. Am J Psychiatry (1986) 1.20
Frontal cortex and basal ganglia metabolic rates assessed by positron emission tomography with [18F]2-deoxyglucose in affective illness. J Affect Disord (1986) 1.20
Neuronal cyclooxygenase 2 expression in the hippocampal formation as a function of the clinical progression of Alzheimer disease. Arch Neurol (2001) 1.17
Physostigmine: improvement of long-term memory processes in normal humans. Science (1978) 1.16
Alzheimer's disease. Morbid risk among first-degree relatives approximates 50% by 90 years of age. Arch Gen Psychiatry (1987) 1.16
Diagnosis of manic episodes in adolescent inpatients: structured diagnostic procedures compared to clinical chart diagnoses. Psychiatry Res (2001) 1.15
Correlation between Abetax-40-, Abetax-42-, and Abetax-43-containing amyloid plaques and cognitive decline. Arch Neurol (2001) 1.15
Neuropsychological test performance in African-American and white patients with Alzheimer's disease. Neurology (1995) 1.14
A study of the reliability of the family history method in genetic studies of Alzheimer disease. Alzheimer Dis Assoc Disord (1989) 1.13
The biochemical high-risk paradigm: behavioral and familial correlates of low platelet monoamine oxidase activity. Science (1976) 1.13
Differential amygdala activation during emotional decision and recognition memory tasks using unpleasant words: an fMRI study. Neuropsychologia (2001) 1.12
Evidence of a locus for schizophrenia and related disorders on the short arm of chromosome 5 in a large pedigree. Am J Med Genet (1996) 1.12
AMPA potentiator treatment of cognitive deficits in Alzheimer disease. Neurology (2007) 1.10
Magnetic resonance imaging of the thalamic mediodorsal nucleus and pulvinar in schizophrenia and schizotypal personality disorder. Arch Gen Psychiatry (2001) 1.09
Dextroamphetamine: cognitive and behavioral effects in normal prepubertal boys. Science (1978) 1.09
The validity of the family history method for identifying Alzheimer disease. Arch Neurol (1997) 1.09
Genetic epidemiological study of maternal and paternal transmission of Alzheimer's disease. Am J Med Genet (1999) 1.09
Hypofrontality in unmedicated schizophrenia patients studied with PET during performance of a serial verbal learning task. Schizophr Res (2000) 1.09
Empirical assessment of the factorial structure of clinical symptoms in schizophrenia: negative symptoms. Psychiatry Res (1992) 1.09
Alzheimer's Disease Assessment Scale (ADAS). Psychopharmacol Bull (1988) 1.08
Are the interpersonal and identity disturbances in the borderline personality disorder criteria linked to the traits of affective instability and impulsivity? J Pers Disord (2001) 1.07
Source monitoring deficits in patients with schizophrenia; a multinomial modelling analysis. Psychol Med (1999) 1.07
The effect of sleep deprivation on cerebral glucose metabolic rate in normal humans assessed with positron emission tomography. Sleep (1991) 1.07